A CONTINUOUS SEQUENCE OF MORE THAN 70 AMINO-ACIDS IS ESSENTIAL FOR ANTIBODY-BINDING TO THE DOMINANT ANTIGENIC SITE OF GLYCOPROTEIN GP58 OF HUMAN CYTOMEGALOVIRUS

被引:70
作者
WAGNER, B
KROPFF, B
KALBACHER, H
BRITT, W
SUNDQVIST, VA
OSTBERG, L
MACH, M
机构
[1] UNIV ERLANGEN NURNBERG, INST KLIN & MOLEC VIROL, LOSCHGESTR 7, W-8520 ERLANGEN, GERMANY
[2] UNIV TUBINGEN, MED NAT WISSENSCHAFTLICHES FORSCHUNGZENTRUM, W-7400 TUBINGEN 1, GERMANY
[3] UNIV ALABAMA, DEPT PEDIAT, BIRMINGHAM, AL 35294 USA
[4] NATL BACTERIOL LAB, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[5] KAROLINSKA INST, S-10521 STOCKHOLM, SWEDEN
[6] SANDOZ INC, RES INST, E HANOVER, NJ 07936 USA
关键词
D O I
10.1128/JVI.66.9.5290-5297.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antigenic domain 1 (AD-1) on glycoprotein gp58 of human cytomegalovirus was characterized in detail, using mouse and human monoclonal antibodies as well as human convalescent sera. Series of procaryotically expressed fusion proteins and synthetic peptides of various lengths were used as sources of antigen. Binding of antibodies was found to depend on a continuous sequence of more than 70 amino acids between residues 552 and 635 of gp58. The fine specificities for sequences involved in antibody binding were (i) amino acids 557 to 635 for neutralizing as well as nonneutralizing mouse monoclonal antibodies, (ii) amino acids 552 to 630 for a neutralizing human monoclonal antibody, and (iii) amino acids 557 to 630 for antibodies present in human sera. Experiments involving fragments of AD-1, presented either as procaryotically expressed fusion protein or as synthetic peptides, indicated that the intact structure was required for recognition of AD-1 by antibodies.
引用
收藏
页码:5290 / 5297
页数:8
相关论文
共 42 条
[11]   USE OF THE POLYMERASE CHAIN-REACTION TO ANALYZE SEQUENCE VARIATION WITHIN A MAJOR NEUTRALIZING EPITOPE OF GLYCOPROTEIN-B (GP58) IN CLINICAL ISOLATES OF HUMAN CYTOMEGALOVIRUS [J].
DARLINGTON, J ;
SUPER, M ;
PATEL, K ;
GRUNDY, JE ;
GRIFFITHS, PD ;
EMERY, VC .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :1985-1989
[12]   RHESUS-MONKEY RESPONSES TO MULTIPLE INJECTIONS OF HUMAN MONOCLONAL-ANTIBODIES [J].
EHRLICH, PH ;
HARFELDT, KE ;
JUSTICE, JC ;
MOUSTAFA, ZA ;
OSTBERG, L .
HYBRIDOMA, 1987, 6 (02) :151-160
[13]   CLEAVAGE AND PURIFICATION OF PROKARYOTICALLY EXPRESSED HIV GAG AND ENV FUSION PROTEINS FOR DETECTION OF HIV ANTIBODIES IN THE ELISA [J].
ELLINGER, S ;
MACH, M ;
KORN, K ;
JAHN, G .
VIROLOGY, 1991, 180 (02) :811-813
[14]   CHARACTERIZATION OF GLYCOPROTEIN COMPLEXES PRESENT IN HUMAN CYTOMEGALOVIRUS ENVELOPES [J].
FARRAR, GH ;
GREENAWAY, PJ .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :1469-1473
[15]  
GONCZOL E, 1990, CURR TOP MICROBIOL, V154, P255
[16]   IDENTIFICATION AND CHARACTERIZATION OF 3 DISTINCT FAMILIES OF GLYCOPROTEIN COMPLEXES IN THE ENVELOPES OF HUMAN CYTOMEGALO-VIRUS [J].
GRETCH, DR ;
KARI, B ;
RASMUSSEN, L ;
GEHRZ, RC ;
STINSKI, MF .
JOURNAL OF VIROLOGY, 1988, 62 (03) :875-881
[17]   CHARACTERIZATION OF A HUMAN CYTOMEGALO-VIRUS GLYCOPROTEIN COMPLEX (GCI) [J].
GRETCH, DR ;
GEHRZ, RC ;
STINSKI, MF .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :1205-1215
[19]   BIOCHEMICAL AND IMMUNOLOGICAL ANALYSIS OF DISCONTINUOUS EPITOPES IN THE FAMILY OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN COMPLEXES DESIGNATED GC-I [J].
KARI, B ;
GEHRZ, R .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :1975-1983
[20]  
KNAPP S, 1990, BIOTECHNIQUES, V8, P280